Article Details

Long-Term Sotatercept Efficacy in Pulmonary Arterial Hypertension - Pulmonology Advisor

Retrieved on: 2022-05-31 18:19:10

Tags for this article:

Click the tags to see associated articles and topics

Long-Term Sotatercept Efficacy in Pulmonary Arterial Hypertension - Pulmonology Advisor. View article details on HISWAI: https://www.pulmonologyadvisor.com/home/meetings/ats-2022/ats-2022-in-depth-pah/long-term-sotatercept-efficacy-in-pulmonary-arterial-hypertension/

Excerpt

Sotatercept treatment for 12 to 18 months proved efficacious and safe, an open-label extension study of the PULSAR trial found.

Article found on: www.pulmonologyadvisor.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up